1. Home
  2. MTSI vs CORT Comparison

MTSI vs CORT Comparison

Compare MTSI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSI
  • CORT
  • Stock Information
  • Founded
  • MTSI 1950
  • CORT 1998
  • Country
  • MTSI United States
  • CORT United States
  • Employees
  • MTSI N/A
  • CORT N/A
  • Industry
  • MTSI Semiconductors
  • CORT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTSI Technology
  • CORT Health Care
  • Exchange
  • MTSI Nasdaq
  • CORT Nasdaq
  • Market Cap
  • MTSI 9.2B
  • CORT 8.1B
  • IPO Year
  • MTSI 2012
  • CORT N/A
  • Fundamental
  • Price
  • MTSI $136.99
  • CORT $71.38
  • Analyst Decision
  • MTSI Strong Buy
  • CORT Strong Buy
  • Analyst Count
  • MTSI 9
  • CORT 4
  • Target Price
  • MTSI $130.00
  • CORT $142.00
  • AVG Volume (30 Days)
  • MTSI 593.0K
  • CORT 1.4M
  • Earning Date
  • MTSI 07-31-2025
  • CORT 07-28-2025
  • Dividend Yield
  • MTSI N/A
  • CORT N/A
  • EPS Growth
  • MTSI N/A
  • CORT 8.36
  • EPS
  • MTSI N/A
  • CORT 1.14
  • Revenue
  • MTSI $845,205,000.00
  • CORT $685,446,000.00
  • Revenue This Year
  • MTSI $33.87
  • CORT $35.85
  • Revenue Next Year
  • MTSI $12.63
  • CORT $35.22
  • P/E Ratio
  • MTSI N/A
  • CORT $62.59
  • Revenue Growth
  • MTSI 32.63
  • CORT 30.93
  • 52 Week Low
  • MTSI $84.00
  • CORT $28.10
  • 52 Week High
  • MTSI $152.50
  • CORT $117.33
  • Technical
  • Relative Strength Index (RSI)
  • MTSI 71.83
  • CORT 48.38
  • Support Level
  • MTSI $128.74
  • CORT $69.60
  • Resistance Level
  • MTSI $134.47
  • CORT $73.13
  • Average True Range (ATR)
  • MTSI 3.27
  • CORT 3.50
  • MACD
  • MTSI 0.31
  • CORT -0.18
  • Stochastic Oscillator
  • MTSI 95.61
  • CORT 24.77

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: